# Effect Of Meloxicam Versus Placebo In Mainland Chinese Patients With Osteoarthritis Of The Knee

> **NCT01430559** · NA · COMPLETED · sponsor: **Pfizer** · enrollment: 408 (actual)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **DRUG:** Meloxicam
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01430559
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10-24
- **Primary completion:** 2013-03-27
- **Final completion:** 2013-03-27
- **Target enrollment:** 408 (ACTUAL)
- **Last updated:** 2020-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01430559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01430559, "Effect Of Meloxicam Versus Placebo In Mainland Chinese Patients With Osteoarthritis Of The Knee". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01430559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*